Preethi Sundaram - 11 Nov 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Strategy Officer
Signature
/s/ Preethi Sundaram
Issuer symbol
CPRX
Transactions as of
11 Nov 2022
Net transactions value
-$618,116
Form type
4
Filing time
15 Nov 2022, 16:01:17 UTC
Previous filing
16 Sep 2022
Next filing
29 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $311,755 +56,786 $5.49 56,786 11 Nov 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $461,386 -28,393 -50% $16.25 28,393 11 Nov 2022 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $468,484 -28,393 -100% $16.50 0 11 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -56,786 -14% $0.000000 342,500 11 Nov 2022 Common Stock 56,786 $5.49 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons and not as a result of any disagreement with the Registrant. Dr. Sundaram remains an officer of the Company.